home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Understanding Pharma: Business Growth and Drivers

 
  December 13, 2007  
     
 
The Center for Professional Advancement, An Online Training Format
February 12, 2008


Who Should Attend
This course is an excellent foundation for planning and implementing program development and change, in both the small-molecule and biologic drug industries. The course extends from the present through 2020, considered by industry observers as the vital reshaping period for Pharma. It is recommended for:

  • Development and production program managers
  • New-product oversight leaders
  • Quality Risk Managers
  • Department and group managers
  • New senior-staff employees
  • Investors and business developers

 

Description
This intensive 90-minute course focuses on these key industry drivers: change in the global market mix, product pipelines, generics, product life cycle, development & manufacturing efficiency, emerging biologics, and profits. Following benchmark review, the course provides footprints for turnaround strategies.

Module 1:

  • The evolving global drug business
  • Industry benchmarks
  • How did we get here?
  • Where we are going

    Module 2:
  • Pipeline and product issues
  • Lifting the regulatory veil
  • The new ethical, biologic and generic drug mix
  • Critical path and Quality Risk Management

    Module 3:
  • Risk & reward from development through manufacturing
  • Niche focus for drug products
  • Outsourcing and plant capacity
  • Turnaround strategies
  •  
     
    Organized by: The Center for Professional Advancement
    Invited Speakers: John E. Carroll, C.Ph.C. is Managing Partner, Cadrai Technology Group and President, Carroll Ventures, Inc. The Cadrai Technology Group develops and presents focused training programs for issues germane to the current needs of the analytical instrument industry, especially regarding Pharmaceutical applications. As Managing Partner for Cadrai LLC., Mr. Carroll modified and introduced ion mobility spectrometers for cleaning verification, an automated fiber optic/UV sensed dissolution apparatus for rapid pharmaceutical product screening and numerous Near-Infrared spectrometric systems for dedicated pharmaceutical applications. All products used proprietary technology of the principal clients.

    As Pharmaceutical Business Unit Manager, for Perstorp Analytical Instruments (now Foss), Mr. Carroll built a global, sustainable business that saw over 8,000 NIR test instruments placed within the pharmaceutical manufacturing industry.

    Mr. Carroll has a B.A.S in Engineering Technology/Chemistry, a M.B.A. (c) in International Marketing, fifty publications and is the author of “The NIR Desk Reference”, (Carroll, He and Landa) and “The Handbook of FTIR”, (Carroll). He is also the editor of “IR-MS: High sensitivity and selectivity for organic analysis”. (Mattson and Carroll).
     
    Deadline for Abstracts: n/a
     
    Registration: Please click here for registration information.
    E-mail: info@cfpa.com
     
       
     
    home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
     
     
     

    Generated by meetings and positions 5.0 by Kai Garlipp
    WWW: Kai Garlipp, Frank S. Zollmann.
    7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.